Markus Pietsch
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis of heterocyclic compounds
Papers in
- Pharmacology 10
- Cholinesterase and Neurodegenerative Diseases 8
-
- Synthesis and biological activity 5
- Click Chemistry and Applications 4
- Co-authors
- Michael Gütschow (21 shared papers)Andrew David Abell (7 shared papers)Reik Löser (10 shared papers)Robert Wodtke (9 shared papers)Erwin Arno Galinski (1 shared paper)Lars Kuerschner (2 shared papers)Ulf Neumann (2 shared papers)Jens Pietzsch (6 shared papers)
In The Last Decade
Markus Pietsch
51 papers receiving 1k citations
Peers
Comparison fields: 5 of 81
- Pharmacology 161
- Organic Chemistry 323
- Molecular Biology 322
- Neurology 34
- Computational Theory and Mathematics 68
Countries citing papers authored by Markus Pietsch
This map shows the geographic impact of Markus Pietsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Pietsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Pietsch more than expected).
Fields of papers citing papers by Markus Pietsch
This network shows the impact of papers produced by Markus Pietsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Pietsch. The network helps show where Markus Pietsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Pietsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 95 | |
| 2 | 1999 | 83 | |
| 3 | 2006 | 65 | |
| 4 | 2010 | 57 | |
| 5 | 2002 | 52 | |
| 6 | 2015 | 47 | |
| 7 | 2011 | 42 | |
| 8 | 2013 | 40 | |
| 9 | 2008 | 38 | |
| 10 | 2014 | 36 | |
| 11 | 2009 | 35 | |
| 12 | 2013 | 32 | |
| 13 | 2018 | 30 | |
| 14 | 2019 | 30 | |
| 15 | 2013 | 28 | |
| 16 | 2005 | 27 | |
| 17 | 2013 | 26 | |
| 18 | 2021 | 23 | |
| 19 | 2015 | 21 | |
| 20 | 2020 | 20 |
About Markus Pietsch
Markus Pietsch is a scholar working on Pharmacology, Organic Chemistry, Molecular Biology, Cancer Research and Computational Theory and Mathematics, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (10 papers), Cholinesterase and Neurodegenerative Diseases (8 papers), Protease and Inhibitor Mechanisms (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Synthesis and biological activity (5 papers), Protein Structure and Dynamics (5 papers), Click Chemistry and Applications (4 papers) and Computational Drug Discovery Methods (4 papers). The work is most often cited by research in Pharmacology (161 citations), Organic Chemistry (323 citations), Molecular Biology (322 citations), Neurology (34 citations) and Computational Theory and Mathematics (68 citations). Markus Pietsch has collaborated with scholars based in Germany, Australia and Denmark. Frequent co-authors include Michael Gütschow, Andrew David Abell, Reik Löser, Robert Wodtke, Erwin Arno Galinski, Lars Kuerschner, Ulf Neumann, Jens Pietzsch, Steven Ballet and Kurt Eger. Their work appears in journals such as ChemMedChem, Journal of Medicinal Chemistry, Analytical Biochemistry, International Journal of Molecular Sciences and Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.